• Facets (new session)
• Description
• Metadata
• Settings
  • Rule: asEquivalentb3sb3sifpdbprdf-labelfacetshttp://dbpedia.org/resource/inference/rules/dbpedia#http://dbpedia.org/resource/inference/rules/opencyc#http://dbpedia.org/resource/inference/rules/umbel#http://dbpedia.org/resource/inference/rules/yago#http://dbpedia.org/schema/property_rules#http://www.ontologyportal.org/inference/rules/SUMO#http://www.ontologyportal.org/inference/rules/WordNet#http://www.w3.org/2002/07/owl#ldpoplwebskos-transvirtpivot-rulesvirtrdf-labelNone
    
  • Inverse Functional Properties: Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects
  • "Same As": Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects (recommended) Apply to subjects, objects and predicates (not recommended on big datasets) Apply to predicates only (special use cases only)

About: Kosan Biosciences     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : yago:WikicatOrganizationsEstablishedIn1995, within Data Space : dbpedia.org associated with source document(s)

Type: Thingcompanyschema:Organizationyago:Organization108008335yago:SocialGroup107950920yago:YagoLegalActoryago:YagoLegalActorGeoyago:YagoPermanentlyLocatedEntityyago:WikicatTechnologyCompaniesBasedInTheSanFranciscoBayAreadul:SocialPersondul:Agentagentwikidata:Q24229398OrganizationBusinessyago:WikicatCompaniesBasedInHayward,Californiaorganisationyago:Abstraction100002137yago:Company108058098yago:Group100031264yago:Institution108053576yago:WikicatOrganizationsEstablishedIn1995 New Facet based on Instances of this Class

Kosan Biosciences, Inc. (stock symbol: KOSN), is a pharmaceutical company which deals with cancer therapeutics medications. The company is currently working on advancing two new classes of anticancer agents through clinical development: heat shock protein 90 (Hsp90) inhibitors and epothilones. Founded in 1995, Kosan is headquartered in Hayward, California and currently has approximately 90 employees. Kosan was funded in part as a venture capital start-up with funds from Sofinnova Ventures of California. On June 26, 2008, Kosan Biosciences was acquired by Bristol-Myers Squibb.